51³Ô¹ÏÍø

Tag - drugmakers

 
Menu
Search
 
July 24, 2026
 

Home Delivery
Subscribe for more access

DRUGMAKERS

Tomomi Goto speaks during an interview in Tokyo on March 17. Goto heads a group of plaintiffs in Tokyo who contracted HIV through the administration of untreated blood products.
51³Ô¹ÏÍø / Crime & Legal
Mar 29, 2026
Settlement of HIV-tainted blood scandal marks 30 years
Tomomi Goto, 53, who currently leads a group of plaintiffs in Tokyo, warns that prejudice and discrimination against people with infectious diseases remain unresolved.
Japan Times
WORLD / Science & Health
Apr 19, 2022
Scientists question data behind an experimental Alzheimer¡¯s drug
Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.
Japan Times
WORLD
Dec 21, 2021
EU backs Novavax shot as region¡¯s fifth COVID-19 vaccine
It is not clear yet how Novavax performs against the omicron variant, or whether a booster dose will be needed.
Japan Times
WORLD
Nov 27, 2021
Merck says its antiviral pill is less effective in final analysis
A final analysis of a clinical trial said the antiviral pill reduced the risk of hospitalization and death among high-risk COVID patients by 30%, down from an earlier estimate of 50%.
Japan Times
ASIA PACIFIC
Nov 8, 2021
South Korea to purchase 70,000 courses of new Pfizer COVID-19 pill
Pfizer has said trial results showed that its Paxlovid pill reduced by 89% the risk of hospitalization or death in some patients.
Japan Times
WORLD / Science & Health / ANALYSIS
Nov 6, 2021
Pfizer results open door to new chapter for COVID treatments
The world needs an easy-to-take COVID-19 treatment. Pfizer Inc.¡¯s and Merck & Co. Inc.¡¯s new pills may be just that. But questions remain about their safety and how well they will work.
Japan Times
WORLD
Oct 30, 2021
Pfizer won the first round, but Moderna sees final victory ahead
Pfizer has been first across the finish line in nearly every leg of the COVID-19 vaccine race, but Moderna executives say their company¡¯s mRNA technology gives it an advantage.
51³Ô¹ÏÍø / Explainer
Oct 20, 2021
Oral drug molnupiravir seen as ¡®trump card¡¯ in Japan¡¯s battle against COVID-19
The treatment developed by Merck could receive fast-track approval by the end of the year, and other oral drugs to fight the coronavirus are not far behind.
Japan Times
WORLD / Science & Health
Oct 2, 2021
Merck pill seen as ¡®huge advance,¡¯ raises hope of preventing COVID-19 deaths
An experimental antiviral pill developed by Merck & Co. could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19.
Japan Times
WORLD
Apr 11, 2021
South African variant can ¡®break through¡¯ Pfizer vaccine, Israeli study says
The study suggests the vaccine is less effective against the South African variant, compared with the original coronavirus and a variant first identified in Britain.
Japan Times
WORLD / Science & Health
Mar 20, 2021
Scientists probe new theories on whether AstraZeneca shot linked to blood clots
Scientists are exploring several possibilities that might explain at least 18 reports of extremely rare blood clots in the brain that occurred in individuals in the days and weeks after receiving the AstraZeneca COVID-19 vaccine.
Japan Times
COMMENTARY / World
Sep 11, 2020
Traders are getting smarter about the vaccine race
Investors watching the COVID-19 vaccine development process could be forgiven for thinking it¡¯s not so hard. The effort has moved extraordinarily quickly so far, and with few hiccups.
Japan Times
BUSINESS / Companies
Jan 22, 2019
Japan drugmaker Takeda mulls sale of $3 billion in emerging-market assets
Takeda Pharmaceutical Co. is considering a sale of some emerging-market drugs as it expands a push to cut debt after buying Shire PLC for $62 billion, according to sources.
Japan Times
BUSINESS / Companies
Jan 9, 2019
Takeda¡¯s CEO says it needs to sell assets quickly to cut debt
The sooner, the better.
Japan Times
BUSINESS / Companies / ANALYSIS
Dec 6, 2018
Takeda downgrade looms after shareholders approve Shire deal
Takeda Pharmaceutical Co. shareholders¡¯ approval of the $62 billion (about ?7 trillion) acquisition of Shire PLC is good news for its bosses¡¯ ambitions to build a global drug giant ¡ª but bad news for its credit ratings.
Japan Times
BUSINESS / Companies
Oct 29, 2018
Takeda may sell some European over-the-counter assets as it seeks to slash debt
Takeda Pharmaceutical Co. is considering a sale of assets from its over-the-counter business in Europe, as the drugmaker pursues ways to cut debt after its $62 billion takeover of Shire PLC, people familiar with the matter said.
Japan Times
BUSINESS / Companies / ANALYSIS
Apr 26, 2018
Shire bid marks Takeda¡¯s latest and biggest push for global status
Takeda Pharmaceutical Co. Ltd..¡¯s $64 billion bid for London-listed rare-disease specialist Shire PLC bolsters its credentials as Japan¡¯s most outward-facing drugs firm, a mold-breaking image that has been more than a decade in the making.
BUSINESS / Companies
Apr 21, 2018
Japanese drugmaker Takeda adds more cash to Shire bid, sending offer past $60 billion
Takeda Pharmaceutical Co. sweetened its offer for drugmaker Shire PLC to more than $60 billion after three prior bids were rejected, wooing investors in the U.S. company with a higher cash component.
Japan Times
BUSINESS / Companies
Jan 14, 2016
As fortunes fade at home, drug giant Takeda eyes greener shores overseas
One balmy summer evening last year, some of the most prolific biotech and scientific minds of Boston came together.
Japan Times
BUSINESS / Companies
Sep 23, 2015
Turing CEO will lower price of $750-a-pill antibiotic ¡ª but doesn¡¯t say how much
Martin Shkreli, chief executive officer of Turing Pharmaceuticals AG, said he would lower the price of the drug Daraprim after being criticized for boosting it fifty-fold to $750 a pill.
Japan scientists identify clusters of protein believed to trigger Alzheimer¡¯s disease
A team of researchers said they found a ¡°seed¡± that accelerates the amyloid beta accumulation process in the brain, naming it ¡°Peak 1 amyloid beta,¡± as seen in a mouse's brain.
Indian brothers make manga debut in Japan
Two Indian brothers made their manga debut in Japan with "Kung Fu Kung Fool" ¡ª an action-comedy series that follows the adventures of a notorious thief and a young boy.
Japan weighs regulating Pokemon cards amid trading mania
A Pokemon event is held in Jakarta on July 11
Low-income families in Japan cut food and air conditioning during summer break
Yumiko Watanabe, the chairperson of nonprofit Kidsdoor, explains the results of a survey in Tokyo's Chiyoda Ward on July 1.
Iran strikes on CIA facilities prompt questions about possible Russian role
Iranian drones are displayed in an undisclosed location in Iran, in this handout image obtained on Jan. 13, 2025.U.S. officials have acknowledged that Russia has ?provided targeting ?and other support for Iran in its drone strikes on U.S. targets in the Persian Gulf region.
The sci-fi sensibilities of electronic trio Black Boboi
Black Boboi was formed in 2018 when solo artists Julia Shortreed, Utena Kobayashi and Ermhoi came together under Kobayashi¡¯s newly founded label, Bindividual.
A perfect storm: Kaze Fujii fans flock to Fuji Rock
Okayama-born singer-songwriter Kaze Fujii has carved out a distinctive place in Japanese pop since his major-label debut in 2019.
Can Japanese comedy get laughs in English? Yoshimoto Kogyo lets the jokes rip
Wes-P has millions of followers and his viral clips made him recognizable out of Japan.
The 180-day locals: Life on Japan¡¯s digital nomad visa
Christopher Flinn works remotely from Tokyo earlier this month. Japan issued 646 digital nomad visas in 2025, but tourism officials are hoping to increase that figure in the coming years, with Japan's relatively cheap cost of living and the weak yen seen as potential draws for young professionals.
Japan reveals hint of new defense spending target in fiscal blueprint
The Self-Defense Forces' Type 16 mobile combat vehicle fires during a joint live-fire drill with U.S. Marines as part of the annual Resolute Dragon exercises in Yufu, Oita Prefecture, on June 28.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo¡¯s Shinjuku Ward.
Kabukicho: Tokyo¡¯s ¡®stadium of desire¡¯

Longform

For many people, utility poles and power lines have become such a familiar part of Japan¡¯s landscape that they often go unnoticed.
Why Japan¡¯s utility poles won¡¯t be disappearing anytime soon
By Alex K.T. Martin

SUSTAINABLE 51³Ô¹ÏÍø

SPECIAL SUPPLEMENTS note

SUPPLEMENTS BINDER